{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:11:36Z","timestamp":1764785496696,"version":"build-2065373602"},"reference-count":102,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["CA85868","CA122019","CA130295"],"award-info":[{"award-number":["CA85868","CA122019","CA130295"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>A major reason for the failure of the immune system to detect tumor antigens (TAs) is the insufficient uptake, processing, and presentation of TAs by antigen-presenting cells (APCs). The immunogenicity of TAs in the individual patient can be markedly increased by the in situ targeting of tumor cells for robust uptake by APCs, without the need to identify and characterize the TAs. This is feasible by the intra-tumoral injection of \u03b1-gal micelles comprised of glycolipids presenting the carbohydrate-antigen \u201c\u03b1-gal epitope\u201d (Gal\u03b11-3Gal\u03b21-4GlcNAc-R). Humans produce a natural antibody called \u201canti-Gal\u201d (constituting ~1% of immunoglobulins), which binds to \u03b1-gal epitopes. Tumor-injected \u03b1-gal micelles spontaneously insert into tumor cell membranes, so that multiple \u03b1-gal epitopes are presented on tumor cells. Anti-Gal binding to these epitopes activates the complement system, resulting in the killing of tumor cells, and the recruitment of multiple APCs (dendritic cells and macrophages) into treated tumors by the chemotactic complement cleavage peptides C5a and C3a. In this process of converting the treated tumor into a personalized TA vaccine, the recruited APC phagocytose anti-Gal opsonized tumor cells and cell membranes, process the internalized TAs and transport them to regional lymph-nodes. TA peptides presented on APCs activate TA-specific T cells to proliferate and destroy the metastatic tumor cells presenting the TAs. Studies in anti-Gal-producing mice demonstrated the induction of effective protection against distant metastases of the highly tumorigenic B16 melanoma following injection of natural and synthetic \u03b1-gal micelles into primary tumors. This treatment was further found to synergize with checkpoint inhibitor therapy by the anti-PD1 antibody. Phase-1 clinical trials indicated that \u03b1-gal micelle immunotherapy is safe and can induce the infiltration of CD4+ and CD8+ T cells into untreated distant metastases. It is suggested that, in addition to converting treated metastases into an autologous TA vaccine, this treatment should be considered as a neoadjuvant therapy, administering \u03b1-gal micelles into primary tumors immediately following their detection. Such an immunotherapy will convert tumors into a personalized anti-TA vaccine for the period prior to their resection.<\/jats:p>","DOI":"10.3390\/pharmaceutics16101263","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:19:33Z","timestamp":1727435973000},"page":"1263","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Self-Tumor Antigens in Solid Tumors Turned into Vaccines by \u03b1-gal Micelle Immunotherapy"],"prefix":"10.3390","volume":"16","author":[{"given":"Uri","family":"Galili","sequence":"first","affiliation":[{"name":"Department of Medicine, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1084\/jem.186.7.1177","article-title":"Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors","volume":"186","author":"Askely","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","article-title":"Progress in human tumour immunology and immunotherapy","volume":"411","author":"Rosenberg","year":"2001","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers","volume":"318","author":"Wood","year":"2007","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","article-title":"Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction","volume":"29","author":"Mlecnik","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intra-tumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2340\/1651-226X.2024.33008","article-title":"The Tumor Immune Microenvironment in Breast Cancer Progression","volume":"63","author":"Huse","year":"2024","journal-title":"Acta Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-023-07233-2","article-title":"High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy","volume":"205","author":"Wood","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: The next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2297453","DOI":"10.1080\/21645515.2023.2297453","article-title":"Toll-like receptor agonists as cancer vaccine adjuvants","volume":"20","author":"Jeon","year":"2024","journal-title":"Hum. Vaccine Immunother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature09460","article-title":"The patterns and dynamics of genomic instability in metastatic pancreatic cancer","volume":"467","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"doi-asserted-by":"crossref","unstructured":"Efremova, M., Finotello, F., Rieder, D., and Trajanoski, Z. (2017). Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy. Front. Immunol., 8.","key":"ref_15","DOI":"10.3389\/fimmu.2017.01679"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2100588118","DOI":"10.1073\/pnas.2100588118","article-title":"Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer","volume":"118","author":"Wei","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2303799","DOI":"10.1080\/21645515.2024.2303799","article-title":"Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies","volume":"20","author":"Aparicio","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00262-023-03413-7","article-title":"Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire","volume":"72","author":"Millar","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12110","article-title":"Anti-Gal: An abundant human natural antibody of multiple pathogeneses and clinical benefits","volume":"140","author":"Galili","year":"2013","journal-title":"Immunology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.160.5.1519","article-title":"A unique natural human IgG antibody with anti-\u03b1-galactosyl specificity","volume":"160","author":"Galili","year":"1984","journal-title":"J. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/iai.56.7.1730-1737.1988","article-title":"Interaction between human natural anti-\u03b1-galactosyl immunoglobulin G and bacteria of the human flora","volume":"56","author":"Galili","year":"1988","journal-title":"Infect. Immun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1128\/IAI.70.11.6215-6222.2002","article-title":"Induction of cytolytic anti-Gal antibodies in \u03b1-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria","volume":"70","author":"Posekany","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1034\/j.1399-3089.2001.00082.x","article-title":"Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural \u03b1-galactosyl IgG antibodies","volume":"8","author":"Blanco","year":"2001","journal-title":"Xenotransplantation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood.V82.8.2485.2485","article-title":"One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody","volume":"82","author":"Galili","year":"1993","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/cdli.2.2.125-131.1995","article-title":"Human secretions contain IgA, IgG and IgM anti-Gal [anti-\u03b1-galactosyl] antibodies","volume":"2","author":"Hamadeh","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007890-199701270-00002","article-title":"Anti-Gal IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation","volume":"63","author":"Minanov","year":"1997","journal-title":"Transplantation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1053-2498(00)00196-0","article-title":"Anti-Gal\u03b11-3Gal IgM\/IgG antibody levels in infants: Do they have a clinical relevance in pediatric xenotransplantation?","volume":"19","author":"Doenz","year":"2000","journal-title":"J. Heart Lung Transpl."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2015.02.001","article-title":"Anti-gal IgM, IgA and IgG natural antibodies in childhood","volume":"164","author":"Hamanova","year":"2015","journal-title":"Immunol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1084\/jem.162.2.573","article-title":"Human natural anti-\u03b1-galactosyl IgG. II. The specific recognition of \u03b1[1,3]-linked galactose residues","volume":"162","author":"Galili","year":"1985","journal-title":"J. Exp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.165.3.693","article-title":"The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies","volume":"165","author":"Galili","year":"1987","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1084\/jem.166.2.419","article-title":"Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl [\u03b11-3]-galactose epitopes","volume":"166","author":"Towbin","year":"1987","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/glycob\/6.6.599","article-title":"Molecular mimicry in the recognition of glycosphingolipids by Gal\u03b13Gal\u00df4GlcNAc\u00df-binding Clostridium difficile toxin A, human natural anti-\u03b1-galactosyl IgG and the monoclonal antibody Gal-13: Characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor","volume":"6","author":"Teneberg","year":"1996","journal-title":"Glycobiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1073\/pnas.84.5.1369","article-title":"Evolutionary relationship between the anti-Gal antibody and the Gal\u03b11-3Gal epitope in primates","volume":"84","author":"Galili","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17755","DOI":"10.1016\/S0021-9258(19)77900-9","article-title":"Man, apes, and Old-World monkeys differ from other mammals in the expression of \u03b1-galactosyl epitopes on nucleated cells","volume":"263","author":"Galili","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1073\/pnas.86.21.8227","article-title":"Isolation of a cDNA encoding murine UDP galactose: \u00dfD-galactosyl-1,4-N-acetyl-D-glucosaminide \u03b11,3-galactosyltransferase: Expression cloning by gene transfer","volume":"86","author":"Larsen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14290","DOI":"10.1016\/S0021-9258(18)71676-1","article-title":"Bovine \u03b11-3galactosyltransferase: Isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA","volume":"264","author":"Joziasse","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.88.16.7401","article-title":"Gene sequences suggest inactivation of \u03b11-3 galactosyltransferase in catarrhines after the divergence of apes from monkeys","volume":"88","author":"Galili","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1016\/S0021-9258(19)39258-0","article-title":"Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:\u03b2-D-Gal [1,4]-D-GlcNAc \u03b1[1,3]-galactosyltransferase cDNA","volume":"265","author":"Larsen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/imm.13582","article-title":"Paleo-immunology of human anti-carbohydrate antibodies preventing primate extinctions","volume":"168","author":"Galili","year":"2023","journal-title":"Immunology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0167-5699(93)90261-I","article-title":"Interaction of the natural anti-Gal antibody with \u03b1-galactosyl epitopes: A major obstacle for xenotransplantation in humans","volume":"14","author":"Galili","year":"1993","journal-title":"Immunol. Today"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.4049\/jimmunol.146.7.2394","article-title":"Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-\u03b1-galactosyl antibodies","volume":"146","author":"Almeida","year":"1991","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12935-019-1059-8","article-title":"AGI-134: A fully synthetic \u03b1-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models","volume":"19","author":"Shaw","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0966-3274(93)90047-C","article-title":"Identification of \u03b1-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man","volume":"1","author":"Cooper","year":"1993","journal-title":"Transpl. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11391","DOI":"10.1073\/pnas.90.23.11391","article-title":"Anti-pig IgM antibodies in human serum react predominantly with Gal (\u03b1l-3)Gal epitopes","volume":"90","author":"Sandrin","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.154.10.5500","article-title":"Cardiac xenografts between primate species provide evidence for the importance of the \u03b1-galactosyl. determinant in hyperacute rejection","volume":"154","author":"Collins","year":"1995","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.burns.2009.04.002","article-title":"Accelerated healing of skin burns by anti-Gal\/alpha-gal liposomes interaction","volume":"36","author":"Galili","year":"2010","journal-title":"Burns"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.1002324","article-title":"Rapid recruitment and activation of macrophages by anti-Gal\/\u03b1-Gal liposome interaction accelerates wound healing","volume":"186","author":"Wigglesworth","year":"2011","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/wound.2016.0703","article-title":"\u03b1-Gal Nanoparticles in Wound and Burn Healing Acceleration","volume":"6","author":"Galili","year":"2017","journal-title":"Adv. Wound Care"},{"doi-asserted-by":"crossref","unstructured":"Galili, U., Zhu, Z., Chen, J., Goldufsky, J.W., and Schaer, G.L. (2021). Near Complete Repair after Myocardial Infarction in Adult Mice by Altering the Inflammatory Response with Intramyocardial Injection of \u03b1-Gal Nanoparticles. Front. Cardiovasc. Med., 8.","key":"ref_49","DOI":"10.3389\/fcvm.2021.719160"},{"doi-asserted-by":"crossref","unstructured":"Galili, U., Li, J., and Schaer, G.L. (2024). Regeneration in Mice of Injured Skin, Heart, and Spinal Cord by \u03b1-Gal Nanoparticles Recapitulates Regeneration in Amphibians. Nanomaterials, 22.","key":"ref_50","DOI":"10.3390\/nano14080730"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13770-023-00616-y","article-title":"Alpha-Gal Nanoparticles in CNS Trauma: II. Immunomodulation Following Spinal Cord Injury (SCI) Improves Functional Outcomes","volume":"21","author":"Gopalakrishnan","year":"2024","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_52","first-page":"3069","article-title":"Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose","volume":"56","author":"LaTemple","year":"1996","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0167-5699(97)80024-2","article-title":"Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity","volume":"18","author":"Galili","year":"1997","journal-title":"Immunol. Today"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.178.7.4676","article-title":"Intra-tumoral injection of \u03b1-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines","volume":"178","author":"Galili","year":"2007","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"ref_56","first-page":"249","article-title":"The human C3b receptor (CR1)","volume":"18","author":"Weiss","year":"1989","journal-title":"Adv. Nephrol. Necker Hosp."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4049\/jimmunol.91.6.761","article-title":"Enhanced antitoxin responses in irradiated mice elicited by complexes of tetanus toxoid and specific antibody","volume":"91","author":"Stoner","year":"1963","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1084\/jem.173.1.37","article-title":"Effect of antigen\/antibody ratio on macrophage uptake, processing and presentation to T cells of antigen complexed with polyclonal antibodies","volume":"173","author":"Manca","year":"1991","journal-title":"J. Exp. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.4049\/jimmunol.149.11.3477","article-title":"Enhanced antigen presentation using human Fcg receptor (monocyte\/macrophage)-specific immunogens","volume":"149","author":"Gosselin","year":"1992","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1126\/science.6231724","article-title":"Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen","volume":"224","author":"Celis","year":"1984","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/hep.1840070324","article-title":"Modulation of the immunological response to hepatitis B virus by antibodies","volume":"7","author":"Celis","year":"1987","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.77.1.10-24.2003","article-title":"Evidence for antibody-mediated enhancement of simian immunodefi ciency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques","volume":"77","author":"Villinger","year":"2003","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1128\/JVI.00647-07","article-title":"Increased immunogenicity of influenza virus vaccine by anti-Gal mediated targeting to antigen presenting cells","volume":"81","author":"Guay","year":"2007","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1128\/JVI.00310-06","article-title":"Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered to Express Gal\u03b11-3Gal\u03b21-4GlcNAc-R Epitopes","volume":"80","author":"Wang","year":"2006","journal-title":"J. Virol."},{"key":"ref_65","first-page":"625","article-title":"Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: A potential method for immunotherapy using autologous tumor cells","volume":"90","author":"Manches","year":"2005","journal-title":"Haematologica."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"21437","DOI":"10.1074\/jbc.270.37.21437","article-title":"Oocyte Gala1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse","volume":"270","author":"Thall","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-199601150-00004","article-title":"The \u03b1-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation","volume":"61","author":"Tearle","year":"1996","journal-title":"Transplantation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4049\/jimmunol.168.3.1479","article-title":"The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal","volume":"168","author":"Cretin","year":"2002","journal-title":"J. Immunol."},{"key":"ref_69","first-page":"3417","article-title":"Increased immunogenicity of tumor vaccines complexed with anti-Gal: Studies in knockout mice for alpha1,3galactosyltransferase","volume":"59","author":"LaTemple","year":"1999","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/eji.200526146","article-title":"The influence of natural antibody specificity on antigen immunogenicity","volume":"35","author":"Benatuil","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1158\/0008-5472.CAN-05-0627","article-title":"Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes","volume":"65","author":"Rossi","year":"2005","journal-title":"Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/sj.cgt.7700812","article-title":"In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene","volume":"12","author":"Deriy","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-09-4313","article-title":"Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: A novel approach to immunotherapy in pancreatic cancer","volume":"70","author":"Deguchi","year":"2010","journal-title":"Cancer Res."},{"doi-asserted-by":"crossref","unstructured":"Yao, X., Dong, Z., Zhang, Q., Wang, Q., and Lai, D. (2015). Epithelial ovarian cancer stem-like cells expressing \u03b1-gal epitopes increase the immunogenicity of tumor associated antigens. BMC Cancer, 15.","key":"ref_74","DOI":"10.1186\/s12885-015-1973-7"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.vaccine.2019.01.004","article-title":"Novel fusion cells derived from tumor cells expressing the heterologous \u03b1-galactose epitope and dendritic cells effectively target cancer","volume":"37","author":"Mo","year":"2019","journal-title":"Vaccine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.3748\/wjg.v17.i48.5260","article-title":"Hepatocellular Carcinoma-specific Immunotherapy with Synthesized \u03b11,3 Galactosyl Epitope-Pulsed Dendritic Cells and Cytokine-Induced Killer Cells","volume":"17","author":"Qiu","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10147-012-0434-4","article-title":"Pancreatic Carcinoma-specific Immunotherapy Using Synthesised Alpha-Galactosyl Epitope-Activated Immune Responders: Findings from a Pilot Study","volume":"18","author":"Qiu","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcyt.2015.09.012","article-title":"Combination of Cytokine-Induced Killer and Dendritic Cells Pulsed with Antigenic \u03b1-1,3 galactosyl Epitope-Enhanced Lymphoma Cell Membrane for Effective B-Cell Lymphoma Immunotherapy","volume":"18","author":"Qiu","year":"2016","journal-title":"Cytotherapy"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/glycob\/12.2.135","article-title":"Expression of \u03b1-gal Epitopes on HeLa Cells Transduced with Adenovirus Containing \u03b11,3galactosyltransferase cDNA","volume":"12","author":"Deriy","year":"2002","journal-title":"Glycobiology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/oxfordjournals.jbchem.a128881","article-title":"Chemistry of lipids of the posthemolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes in rabbit","volume":"64","author":"Eto","year":"1968","journal-title":"J. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0003-9861(73)90138-0","article-title":"Determination of aminosugar linkage in glycolipids by methylation. Aminosugar linkage of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen","volume":"133","author":"Stellner","year":"1973","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/oxfordjournals.jbchem.a133571","article-title":"Isolation and partial structural characterization of macroglycolipid from rabbit erythrocyte membranes","volume":"90","author":"Honma","year":"1981","journal-title":"J. Biochem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1016\/S0021-9258(17)42840-7","article-title":"Immunochemistry of I\/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Determination of branching patterns of a ceramide pentadecasaccharide by 1H nuclear magnetic resonance","volume":"259","author":"Dabrowski","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1016\/S0021-9258(18)89161-X","article-title":"Immunochemistry of I\/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes","volume":"260","author":"Egge","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-6215(88)80098-3","article-title":"Structure elucidation of blood group B-like and I-active ceramide eicosa-and pentacosasaccharides from rabbit erythrocyte membranes by combined gas chromatography-mass spectrometry; electron-impact and fast atom-bombardment mass spectrometry; and two-dimensional correlated, relayed-coherence transfer, and nuclear Overhauser effect 500-MHz 1H-n.m.r. spectroscopy","volume":"178","author":"Hanfland","year":"1988","journal-title":"Carbohydr. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"unstructured":"Galili, U. (2018). The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine, Academic Press\/Elsevier Publishers.","key":"ref_87"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00007890-199804270-00020","article-title":"A sensitive assay for measuring \u03b1-gal epitope expression on cells by a monoclonal anti-Gal antibody","volume":"65","author":"Galili","year":"1998","journal-title":"Transplantation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/cancers2020773","article-title":"In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intra-tumoral Injections of \u03b1-gal Glycolipids","volume":"2","author":"Galili","year":"2010","journal-title":"Cancers"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1073\/pnas.89.13.6020","article-title":"Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens","volume":"89","author":"Karttunen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.4049\/jimmunol.150.7.2724","article-title":"Endogenous generation and presentation of the ovalbumin peptide\/Kb complex to T cells","volume":"150","author":"Shastri","year":"1993","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/intimm\/6.3.369","article-title":"LacZ inducible, antigen\/MHC-specific T cell hybrids","volume":"6","author":"Sanderson","year":"1994","journal-title":"Int. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00262-009-0662-2","article-title":"Intra-tumoral injection of \u03b1-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity","volume":"58","author":"Wigglesworth","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_95","first-page":"3861","article-title":"Cancer immunotherapy by intra-tumoral injection of \u03b1-gal glycolipids","volume":"32","author":"Whalen","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00262-016-1846-1","article-title":"Phase I study to evaluate toxicity and feasibility of intra-tumoral injection of \u03b1-gal glycolipids in patients with advanced melanoma","volume":"65","author":"Albertini","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1423-0410.2011.01512.x","article-title":"An improved Fc function assay utilizing CMV antigen-coated red blood cells generated with synthetic function-spacer-lipid constructs","volume":"102","author":"Georgakopoulos","year":"2012","journal-title":"Vox Sang."},{"unstructured":"PR Newswire (2022, December 20). BioLineRx Announces Results from Phase 1\/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors. Provided by BioLineRx Ltd. Available online: https:\/\/ir.biolinerx.com\/news-releases\/news-release-details\/biolinerx-announces-results-phase-12a-study-investigational-anti.","key":"ref_98"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40425-017-0218-5","article-title":"Combination immunotherapy: A road map","volume":"5","author":"Ott","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.tp.0000250598.29377.13","article-title":"Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation","volume":"83","author":"Stone","year":"2007","journal-title":"Transplantation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaci.2011.02.019","article-title":"The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-\u03b1-1,3-galactose","volume":"127","author":"Commins","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/all.16003","article-title":"Tick bites, IgE to galactose-alpha-1,3-galactose and urticarial or anaphylactic reactions to mammalian meat: The alpha-gal syndrome","volume":"79","author":"Wilson","year":"2024","journal-title":"Allergy"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/10\/1263\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:05:22Z","timestamp":1760112322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/10\/1263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":102,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["pharmaceutics16101263"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16101263","relation":{},"ISSN":["1999-4923"],"issn-type":[{"type":"electronic","value":"1999-4923"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}